| MacKay, Gerry (Refeyn 202401– CEO before Sartorius + Millipore + BioOutsource) |
Chief Executive Officer (CEO) |
Refeyn (Group) |
United Kingdom (GB) |
| Bonham-Carter, John (Refine Technology 201201 VP Sales + Business Development) |
Sales Manager / Marketing Manager |
Refine Technology LLC |
United States (USA) |
| Brinkmann, Maximilian (Max) (Refined Laser Systems 202301 Managing Director + Co-Founder) |
Managing Director |
Refined Laser Systems GmbH |
Germany |
| Hellwig, Tim (Refined Laser Systems 202301 Managing Director + Co-Founder) |
Managing Director |
Refined Laser Systems GmbH |
Germany |
| Krieg, Arthur (Art) (Checkmate Pharmaceuticals 201508 CEO + Founder) |
Chief Executive Officer (CEO) |
Regeneron (Group) |
United States (USA) |
| Thurston, Gavin (Regeneron 201701 VP Oncology + Angiogenesis) |
cancer |
Regeneron (Group) |
United States (USA) |
| Daminger, Dieter (BioPark Regensburg 201104 Managing Director) |
Managing Director |
Regensburg (govt city) |
Germany |
| Diefenthal, Thomas (BioPark Regensburg 201103 Managing Director) |
Managing Director |
Regensburg (govt city) |
Germany |
| Cottrell, Steve (Maetrics 202009 President) |
President/Director/Head Business Group/Unit/Division |
Regulatory and Quality Solutions (R&G) (Group) |
United States (USA) |
| Fagan, Maria (Regulatory and Quality Solutions 202009 President + Co-Founder) |
Chief Executive Officer (CEO) |
Regulatory and Quality Solutions (R&G) (Group) |
United States (USA) |
| Hüppe, Paul (Rehberg Hüppe + Partner 201409 Patent Attorney) |
Patent Attorney |
Rehberg Hüppe + Partner Patentanwälte PartG mbB (RHP) |
Germany |
| Martí, Laura (Reig Jofré 202312– CFO before Audax Renovables + General Electric) |
Chief Financial Officer (CFO) |
Reig Jofré (Group) |
Spain (España) |
| Cavalli, Fabio (MondoBiotech 200901 CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
| Galfetti, Paolo (APR Applied Pharma Research 201505 CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
| Gramatica, Ruggero (Therametrics –201309 CEO RESIGNED 9/13) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
| Hédou, Gaël (Relief Therapeutics 201610 COO) |
Chief Operating Officer (COO) |
Relief Therapeutics (Group) |
Switzerland |
| Hoppe, Wolfgang (AdVita Lifescience GmbH 201905– Managing Director) |
Managing Director |
Relief Therapeutics (Group) |
Germany |
| Marotta, Marco (Relief Therapeutics 202111– promoted to CBO joined with acquisition of APR Applied Pharma Research) |
Business Development Manager / Strategy Manager |
Relief Therapeutics (Group) |
Switzerland |
| Petrone, Raffaele (Therametrics 201310– CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
| Selvaraju, Raghuram (Ram) (Relief Therapeutics 202010 Board Chairman) |
Board member, non-executive |
Relief Therapeutics (Group) |
Switzerland |
| Weinstein, Jack (Relief Therapeutics 202010– CFO before Avalon Group + Catalyst Pharmaceuticals + Sterlington Group) |
Chief Financial Officer (CFO) |
Relief Therapeutics (Group) |
Switzerland |
| Baltrusch, Andreas (Co.don 201202 CEO) |
Chief Executive Officer (CEO) |
ReLive (Group) |
Germany |
| Bur, Tilmann (ReLive 202301 Managing Director of Co.don GmbH) |
Chief Executive Officer (CEO) |
ReLive (Group) |
Germany |
| Li, Chen (ReLive 202301 Managing Director of Co.don GmbH) |
Chief Executive Officer (CEO) |
ReLive (Group) |
Germany |
| Meißner, Matthias (Co.don 201405 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
ReLive (Group) |
Germany |
| Methner, Vilma (Co.don 201405 COO + CSO) |
Chief Operating Officer (COO) |
ReLive (Group) |
Germany |
| Siodla, Vilma (Co.don 201202 COO) |
Chief Operating Officer (COO) |
ReLive (Group) |
Germany |
| Zhao, Xing (ReLive 202301 CEO + Founder) |
Chief Executive Officer (CEO) |
ReLive (Group) |
|
| Nonomura, Kazuhika (Remiges Ventures 202209 Principal) |
Principal (venture capital) |
Remiges Ventures |
United States (USA) |
| McCullough, James (RenalytixAI 201803– CEO + Renwick Capital 201410– Managing Partner before Exosome Diagnostics) |
Chief Executive Officer (CEO) |
Renalytix AI (Group) |
United Kingdom (GB) |
| Sampers, Thomas (Renolit 202005 Head of Renolit Healthcare) |
President/Director/Head Business Group/Unit/Division |
Renolit (Group) |
Germany |
| Bardroff, Christiane (Rentschler 202212– COO joined 2/22 before Teva Ulm + Roche) |
Chief Operating Officer (COO) |
Rentschler (Group) |
Germany |
| Bhonsle-Deeng, Latika (Rentschler 202308 Senior Director Corporate Coummunication) |
Public Relations Manager / Investor Relations Manager |
Rentschler (Group) |
Germany |
| Blackman, Lorraine (Rentschler 201911– Head Human Resources at Rentschler Biopharma Inc) |
Human Resources Manager |
Rentschler (Group) |
United States (USA) |
| Caswell, Mark (Rentschler 202207– VP Site Head for US Facility before Lonza Biologics + Sanofi Genzyme) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
| Dettmer, Alexander (Rentschler 202007– CFO before Fresenius) |
Chief Financial Officer (CFO) |
Rentschler (Group) |
Germany |
| Glück, Tobias (Rentschler 202210– SVP Human Relations before Novartis Deutschland) |
Human Resources Manager |
Rentschler (Group) |
Germany |
| Kaiser, Cora (Rentschler 201903– Senior Director Corp Communications before MC Services + College Hill Munich) |
Public Relations Manager / Investor Relations Manager |
Rentschler (Group) |
Germany |
| Keßler Martin (Rentschler 202103– SVP Transformation + CEO of Rentschler Biopharma Inc before McKinsey & Co) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Kim, Grace (Rentschler 202002– VP BusDev North America & APAC before Northway Biotechpharma + Samsung Biologics) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
United States (USA) |
| Koehn, Jadranka (Rentschler 202011 Senior Direct Innovation Partnerships) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
United Kingdom (GB) |
| Kumar, Hemant (Rentschler 201911– VP Process Sciences Rentschler Biopharma Inc before AnaptysBio + Merck) |
n. a. |
Rentschler (Group) |
United States (USA) |
| Nuernberger, Falk (Rentschler 202207– Corporate General Counsel before Viatris + MediGene + Sandoz + Actavis) |
General Counsel / Chief Legal Officer (CLO) |
Rentschler (Group) |
Germany |
| Otto, Ralf (Rentschler 201802– COO before McKinsey + Boehringer Ingelheim + Henkel) |
Chief Operating Officer (COO) |
Rentschler (Group) |
Germany |
| Panting, Robert (Rentschler 202110– General Manager of Rentschler ATMP Ltd before Fujifilm Diosynth Biotechnologies) |
General Manager (management) |
Rentschler (Group) |
United Kingdom (GB) |
| Pollano, Federico (Rentschler 201803– SVP BusDev before Polpharma Biologics + Richter-Helm + BioGeneriX) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Rampf, Stefan (Rentschler 201605–2020006 CFO before ABL Technik Entlackung GmbH + Volvo Financial Services LEFT 6/20) |
Chief Financial Officer (CFO) |
Rentschler (Group) |
Germany |
| Rentschler, Nikolaus F. (Rentschler Biotechnologie 201604– Supervisory Board before Managing Director (CEO)) |
Supervisory Board Member |
Rentschler (Group) |
Germany |
| Roberts, Tom (Rentschler 202309– President of Rentschler Biopharma Inc + General Manager US before Vitanova Biomedical) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
| Savage, Karen (Rentschler 201911 VP + Head of Milford Site) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
| Schrader, Marion (Rentschler 201602 Senior Director Company Communication + PR) |
Public Relations Manager / Investor Relations Manager |
Rentschler (Group) |
Germany |
| Starnecker, Alexander (Rentschler 201710 Manager Company Development) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Sydow, Sabine (Rentschler 202207– Chief of Staff before vfa bio + Schering) |
Human Resources Manager |
Rentschler (Group) |
Germany |
| Sälzle, Martina (Rentschler 201812 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Rentschler (Group) |
Germany |
| von Braunmühl, Benedikt (Rentschler 202309– CEO before HMNC Brain Health + Medicover AB + Qiagen + Chiron Vaccines) |
Chief Executive Officer (CEO) |
Rentschler (Group) |
Germany |
| Winterhalter, Christoph (Rentschler –201411–201802 Business Development Manager LEFT 2/18) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Zurdo, Jesús (Rentschler 201911 SVP Innovation + Venture Partnerships) |
n. a. |
Rentschler (Group) |
Germany |
| Seth, Kim (Repare Therapeutics 202206 EVP + Head of Business + Corporate Development) |
Business Development Manager / Strategy Manager |
Repare Therapeutics Inc. (CA) (Nasdq: RPTX) |
Canada |
| Cox, John G. (Repertoire Immune Medicines 202104 CEO formerly Bioverativ 201801 CEO) |
Chief Executive Officer (CEO) |
Repertoire Immune Medicines (Group) |
United States (USA) |
| Woolfson, Adrian (Replay 202208 Executive Chair + Co-Founder before Sangamo + Nouscom + Pfizer + BMS) |
Board member, executive |
Replay (Group) |
United States (USA) |
| Gebski, Christine (Repligen 202308 SVP Filtration + Chromatography before Thermo Fisher) |
President/Director/Head Business Group/Unit/Division |
Repligen Corporation (Nasdaq: RGEN) |
United States (USA) |
| Newman, Sondra S. (Repligen 202308 Global Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Repligen Corporation (Nasdaq: RGEN) |
United States (USA) |
| Blain, David (Reinnervate 200709– CFO) |
Chief Financial Officer (CFO) |
ReproCell (Group) |
United Kingdom (GB) |
| Cooper, Ashley (Reinnervate 200709– CEO) |
Chief Executive Officer (CEO) |
ReproCell (Group) |
United Kingdom (GB) |
| Przyborski, Stefan (Reinnervate 201207 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ReproCell (Group) |
United Kingdom (GB) |
| Ratcliffe, Ian (Stemgent 201303 CEO) |
Chief Executive Officer (CEO) |
ReproCell (Group) |
United States (USA) |
| Toniolo, Alessandro (Resalis Therapeutics 202302 CEO before Pfizer + Novartis) |
Chief Executive Officer (CEO) |
Resalis Therapeutics S.r.l. |
Italy |
| Carrillo, Cristina (ResearachGate 202307) |
n. a. |
ResearchGate (Group) |
Germany |
| Madisch, Iljad (ResearchGATE 201705 Founder) |
Company Founder |
ResearchGate (Group) |
Germany |
| Cichocka, Danuta (Resistell 201912 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Resistell AG |
Switzerland |
| Gonciarz, Grzegorz (Resistell 202007 COO) |
Chief Operating Officer (COO) |
Resistell AG |
Switzerland |
| Jekerle, Katherina (ResMed 202208– Managing Director of Mementor DE GmbH before ResMed Germany) |
Managing Director |
ResMed (Group) |
Germany |
| Lorenz, Noah M. (Mementor 202208 Managing Director + Co-Founder) |
Managing Director |
ResMed (Group) |
Germany |
| Pucknat, Katrin (ResMed 202208 Managin Director of ResMed Germany) |
Managing Director |
ResMed (Group) |
Germany |
| Barbazette, Chris (DNA Script 2ß22ß5– CCO before Resolve Biosciences + EAB Consulting + GenapSys + Agendia + Affymetrix) |
Chief Commercial Officer (CCO) |
Resolve Biosciences GmbH |
Germany |
| Steinberg, Paul (Resolve Biosciences 202210– Chief Commercial Officer before LevitasBio + NanoString + Fluidigm) |
Chief Commercial Officer (CCO) |
Resolve Biosciences GmbH |
Germany |
| Furuishi, Kazuchika (Showa Denko 202009 Head Minaris Regenerative Medicine business + CEO Minaris LLC |
Chief Executive Officer (CEO) |
Resonac (Group) |
United States (USA) |
| Günther, Christine Elfriede (Apceth 201108 Managing Director STEPPED DOWN 2/21) |
Managing Director |
Resonac (Group) |
Germany |
| Hirsch, Christian (Showa Denko 202004 General Manager Shodex Business EMEA at Showa Denko Europe GmbH) |
General Manager (management) |
Resonac (Group) |
Germany |
| Kosijer, Dusan (Apceth 201705– CFO of Apceth Biopharma GmbH joined 10/16 before Accovion GmbH) |
Chief Financial Officer (CFO) |
Resonac (Group) |
Germany |
| Maruyama, Hisashi (Hitachi 201901 CEO of Hitachi Chemical Co. Ltd.) |
Chief Executive Officer (CEO) |
Resonac (Group) |
Japan |
| Preti, Robert A. (Hitachi 201901 CEO Hitachi Chemical Advanced Therapeutics Solutions + General Manager RegMed business) |
Chief Executive Officer (CEO) |
Resonac (Group) |
United States (USA) |
| St-Onge, Luc (Apceth Biopharma 201708 before Ganymed + Affectis CBO + DeveloGen) |
Business Development Manager / Strategy Manager |
Resonac (Group) |
Germany |
| Steinhauser, Lisa (Showa Denko 201306 Customer Support Manager Shodex Businees EMEA + Russia) |
Regional manager |
Resonac (Group) |
Germany |
| Verzetnitsch, Ulrike (Apceth 201612 CTO at Apceth Biopharma GmbH) |
Chief Technology/Technical Officer (CTO) |
Resonac (Group) |
Germany |
| Rubow, Reinhard (Retina Implant 201603 CFO) |
Chief Financial Officer (CFO) |
Retina Implant AG |
Germany |
| Wrobel, Walter-G. (Retina Implant 201603 CEO) |
Chief Executive Officer (CEO) |
Retina Implant AG |
Germany |
| Ciller, Carlos (RetinAI Medical 202012 CEO) |
Chief Executive Officer (CEO) |
RetinAI Medical AG |
Switzerland |
| Reusch, Philipp (Reusch Rechtsanwälte 200809 Saarbrücken) |
n. a. |
Reusch Rechtsanwälte (Saarbrücken) |
Germany |
| Cravens, Aaron (Revel Pharmaceuticals 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Revel Pharmaceuticals (US) |
United States (USA) |
| Baillieu, Francesca (Revent Capital 202310 Investment Manager) |
Investment Manager |
Revent Capital GmbH |
Germany |
| Hoffman, Eric (Reveragen 201611 CEO) |
Chief Executive Officer (CEO) |
Reveragen BioPharma Inc. |
United States (USA) |
| Simsa, Robin (Revo Foods 202209 Managing Director) |
Managing Director |
Revo Foods GmbH |
Austria |
| Harmeier, Anja (Rewind Therapeutics 202301 CEO + Bellevue 202007 Partner at Pureos Bioventures) |
Chief Executive Officer (CEO) |
Rewind Therapeutics N.V. |
Belgium |
| Xi, Hualin (Simon) (Rgenta Therapeutics 202004 CEO + CO-Founder) |
Chief Executive Officer (CEO) |
Rgenta Therapeutics Inc. |
United States (USA) |
| Eistetter, Harald (Rhecadis 201201– Managing Director + Co-Founder before Biognosys CBO + EvalueScience + Indivumed) |
Managing Director |
Rhecadis GmbH |
Germany |
| Dreyer, Malu (Rheinland-Pfalz (govt) 202305 Ministerpräsidentin) |
Minister |
Rheinland-Pfalz (govt region) |
Germany |
| Schmitt, Daniela (Rheinland-Pfalz (govt) 202401 Minister of Economic Affairs) |
Minister |
Rheinland-Pfalz (govt region) |
Germany |
| de Vladar, Harold P. (Ribbon Biolabs 202105 Managing Director + Founder) |
Managing Director |
Ribbon Biolabs GmbH |
Austria |
| Geerds, Arno (Ribocon 2005– co-founder + managing director) |
Managing Director |
Ribocon GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 68 69 70 ... 88 89 90 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
